Instructions for Thiocetam (Piracetam, Thiotriazoline)
Release form
tabbed film coating, 50 mg+200 mg: 30, 50, 60 or 100 pcs
Description:
Tablets covered with a film shell of yellow color, round, double-convex; On the cross section - a white or almost white kernel.
1 tab.
thiotriazolin 50 mg
piracetam 200 mg
Auxiliary substances:
potato starch - 23.47 mg, low molecular weight povidone - 3.5 mg, sucrose (powdered sugar) - 3.5 mg,
microcrystalline cellulose - 66.03 mg,
calcium stearate - 3.5 mg.
Film sheath composition: opadray II yellow (indigocarmine-based aluminium lacquer - 0.0012 mg,
dye-based aluminium lacquer solar sunset yellow - 0.0045 mg,
hypromellose - 2.4 mg,
monohydrate lactose - 1.32 mg,
macrogol - 0.48 mg,
dye-based aluminium lacquer quinoline yellow - 0.21 mg,
titanium dioxide - 1.22 mg,
triacetine - 0.36 mg,
iron oxide yellow - 0.0025 mg) - 6 mg.
10 pcs - box-type contour (3) packages - cardboard packs.
10 pcs - packages of box contour (6) - cardboard packs.
50 pcs - polyethylene terephthalate cans (1) - cardboard packs.
100 pcs - polyethylene terephthalate cans (1) - cardboard packs.
ATC codes
N06BX Other psychostimulants and nootropic drugs Thiocetam
Clinical-pharmacological groups / Group affiliation
A drug Thiocetam that improves brain metabolism
Active substance
- piracetam
- thiotriazolin
Pharmacotherapy group:
Nootropic agent
Storage Conditions
Store the drug Thiocetam in a place inaccessible to children, protected from light at a temperature of 15 to 25 ° C.
Best before date
Shelf life is 2 years. Do not use the product after the expiry date indicated on the package.
Testimony:
chronic brain ischemia;
the recovery period of ischemic stroke (including in patients with non-dementia cognitive impairment);
diabetic encephalopathy.
Method of use, course and dosage:
Inside, 30 minutes before the meal.
For chronic disorders of cerebral circulation and in the recovery period after ischemic stroke 2 pills 3 times/day for 25-30 days. The course of treatment can be extended to 3-4 months.
For the treatment of diabetic encephalopathy, 2 tablets are prescribed 3 times/day for 45 days.
The last dose is taken not later than 17 h (to prevent sleep disturbance).
Application for kidney disorders
It is contraindicated in severe chronic kidney failure (creatinine clearance is less than 20 ml/min).
With caution, the drug Thiocetam is prescribed to patients with chronic kidney failure (creatinine clearance 20-80 ml/min). Thiocetam affects the aggregation of platelets, so it must be used with care for patients with haemostasis disorder, surgical interventions, severe bleeding.
Terms of Sale
The drug is prescription.
Application in elderly patients
Caution should be exercised in elderly persons with cardiovascular pathology due to the fact that in this group of patients there are more frequent adverse reactions.
For long-term therapy in elderly patients, regular monitoring of kidney function is recommended, if necessary, dose correction depending on creatinine clearance.
Use in children
There is no experience with the drug for treating children, so the drug Thiocetam is contraindicated for treating children under 18.
Nosology (ICD codes)
F07
Personality and behavioural disorders caused by disease, damage or brain dysfunction
G93.4
Encephalopathy unrefined
I63
Brain infarction
I69
Effects of cerebrovascular disease
Drugs:
Thiocetam belongs to the group of cerebroactive agents, exhibits nootropic anti-ischemic and antioxidant properties. The pharmacological effect of the drug Thiocetam is due to the mutually potentializing effect of thiotriazolin and piracetam.
Piracetam - cyclic, GABA derivative, nootropic agent; acts directly on the brain, improving functions such as learning, memory, attention and consciousness, without having a sedative or psychostimulating effect
